← Eichor
Condition: Chemo Brain Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemo Brain

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07193654Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06839560Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NA · 2 location(s) · Massachusetts General Hospital · NCT02290834Assessment of Brain Cognitive Impairment in Breast Cancer
Phase N/A · 1 location(s) · Tang-Du Hospital · NCT05305092Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis
Phase 2 · 1 location(s) · Fudan University · NCT06501378The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07535463Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
NA · 1 location(s) · University of Oklahoma · NCT06725953Modified CV Regimen in Optic Pathway Glioma
Phase 2 · 1 location(s) · Beijing Sanbo Brain Hospital · NCT05278715Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
Phase 1 · 1 location(s) · Hospital San Carlos, Madrid · NCT06418113A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Phase 2 · 166 location(s) · Children's Oncology Group · NCT04684368Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment
NA · 1 location(s) · University Medicine Greifswald · NCT04817566Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
Phase 1 · 1 location(s) · Sichuan University · NCT06431685Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumo
Phase 1 · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05293197Improve Cancer-related Cognitive Impairment
NA · 1 location(s) · University of Alabama at Birmingham · NCT05864274Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
NA · 1 location(s) · Hebei Medical University Fourth Hospital · NCT06056115Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT06974370Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemo
NA · 1 location(s) · Charite University, Berlin, Germany · NCT06140875A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal
Phase 3 · 1 location(s) · Allist Pharmaceuticals, Inc. · NCT06970639Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT05840575Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionat
Phase N/A · 1 location(s) · Chang Gung Memorial Hospital · NCT04006561Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard
Phase 1 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07179328Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis
Phase 2 · 1 location(s) · Fudan University · NCT06501391A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients Wit
Phase 2 · 6 location(s) · BioNTech SE · NCT07297212Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-
Phase N/A · 1 location(s) · University of Rochester · NCT03137095Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients
Phase 2 · 3 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07304739Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Phase 3 · 51 location(s) · CarThera · NCT05902169Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study
Phase 4 · 1 location(s) · Chuansheng Zhao · NCT07454473Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery
Phase N/A · 1 location(s) · University of Toronto · NCT04616300
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.